In July, the Florida Department of Health released new guidance encouraging clinicians to take a cautious, comprehensive approach before prescribing psychotropic medications to children ages 5–17. Except in emergencies, it advises providers conduct thorough medical, developmental, and psychosocial evaluations and address factors such as sleep, nutrition, physical activity, screen time, family environment, and potential underlying medical conditions before considering medication.
For children with mild symptoms, the guidance recommends prioritizing evidence-based psychotherapy and other non-pharmacologic interventions. It also emphasizes that children already taking psychiatric medications should be regularly reassessed and, when clinically appropriate, considered for gradual deprescribing rather than abrupt discontinuation. Overall, the guidance highlights informed decision-making, individualized care, and careful consideration of both the potential benefits and risks of psychotropic medications in pediatric patients.
Reference
Florida Department of Health. (2026, July). Guidance: Avoidance of psychotropic pharmacotherapy in children.https://www.floridahealth.gov/wp-content/uploads/2026/07/GUIDANCE-Avoidance_of_Psychotropic_Pharmacotherapy_in_Children.pdf
